InvestorsHub Logo
Followers 1
Posts 518
Boards Moderated 0
Alias Born 06/08/2011

Re: None

Thursday, 04/19/2012 10:49:17 AM

Thursday, April 19, 2012 10:49:17 AM

Post# of 636
i think this article is not considering the fact that
another major drug company could come in with
a more substantial offer. remember, even though
they would not have total rights and profits, they would
have 50% share of -gsk- profits.
that would " in my opinion," twist -gsk- arm to increase
they're bid substantially, just to deter potential buyers.
i think this share price will go to $20. to $25.
it will be interesting to watch.
" I COULD BE WRONG!!"
just remember: this stock was trading at $30.00
exactly one year ago. { 52 week high - 4/28/11

From: Kevin Hyatt <Kevin.Hyatt@comporium.com>
To: Robert Chaney <robertchaneygto@yahoo.com>
Sent: Thursday, April 19, 2012 10:07 AM
Subject: GlaxoSmithKline pounces on Human Genome with $2.6 billion bid

I thought you might be interested in this:

http://reut.rs/IAuCxJ

I found this using the Thomson Reuters News Pro for iPhone app.

To install News Pro on your iPhone or iPad, visit:

http://reuters.com/mobile



Have a great day,
Kevin